Literature DB >> 11699070

Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model.

K Asai1, N Hiki, Y Mimura, T Ogawa, K Unou, M Kaminishi.   

Abstract

Clinical studies demonstrate a better outcome of sepsis in females. Elevated estrogen levels and plasma cytokine imbalance occur in septic patients. We propose that gender-different cytokine secretion by the peripheral blood mononuclear cells (PBMCs) in sepsis determines the clinical outcome. A 2 x 10(6) PBMC sample from healthy volunteers (10 males and 10 females) was incubated with 1 ng/mL of lipopolysaccharide (LPS), estradiol (E2; 0, 0.03, 0.3, 3.0, 30 ng/mL), or 1 ng/mL of LPS + E2 (0, 0.03, 0.3, 3.0, 30 ng/ml), and supernatant cytokine levels were measured. Tumor necrosis factor alpha (TNF alpha) and interleukin (IL)-6 production by PBMCs from both sexes was time-dependently stimulated by LPS. At 6 h after LPS challenge, the TNF alpha level of male PBMCs was significantly higher but IL-6 secretion by female PBMCs was higher (two-way ANOVA: P < 0.05). E2 alone stimulated cytokine secretion by male PBMCs. Addition of the same E2 concentration as in sepsis patients' plasma modulated LPS-induced cytokine production. No significant sex differences in LPS-stimulated TNF alpha or IL-6 secretion by PBMCs were found, but IL-10 secretion by male PBMCs was significantly suppressed. This study demonstrated a gender difference in PBMCs responsiveness to LPS and E2 stimulation and E2-modulated cytokine secretion. In this PBMCs model of sepsis, only the supernatant IL-10 level was significantly lower in males. These ex vivo findings may partially explain the mechanism underlying the poorer outcome of male sepsis patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11699070     DOI: 10.1097/00024382-200116050-00003

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  60 in total

Review 1.  Gender dimorphism in immune responses following trauma and hemorrhage.

Authors:  Yukihiro Yokoyama; Martin G Schwacha; T S Anantha Samy; Kirby I Bland; Irshad H Chaudry
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns.

Authors:  Eric Giannoni; Laurence Guignard; Marlies Knaup Reymond; Matthieu Perreau; Matthias Roth-Kleiner; Thierry Calandra; Thierry Roger
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

3.  Multivariate analysis of cytokine responses identifies distinctive sensitivities to lipopolysaccharide in humans.

Authors:  David D Duncan; Lorrie Tiberio; John H Eldridge
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 4.  Sex-based differences in immune function and responses to vaccination.

Authors:  Sabra L Klein; Ian Marriott; Eleanor N Fish
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01       Impact factor: 2.184

Review 5.  Sexual Dimorphism in Immunity to Oral Bacterial Diseases: Intersection of Neutrophil and Osteoclast Pathobiology.

Authors:  M S Valerio; K L Kirkwood
Journal:  J Dent Res       Date:  2018-09-11       Impact factor: 6.116

6.  Estrogen decreases tight junction protein ZO-1 expression in human primary gut tissues.

Authors:  Zejun Zhou; Lumin Zhang; Miao Ding; Zhenwu Luo; Shao Yuan; Meena B Bansal; Gary Gilkeson; Ren Lang; Wei Jiang
Journal:  Clin Immunol       Date:  2017-09-01       Impact factor: 3.969

7.  Monocyte proinflammatory cytokine release is higher and glucocorticoid sensitivity is lower in middle aged men than in women independent of cardiovascular risk factors.

Authors:  P H Wirtz; R von Känel; N Rohleder; J E Fischer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

8.  Androgen-dependent immune modulation in parasitic infection.

Authors:  Julie Sellau; Marie Groneberg; Hannelore Lotter
Journal:  Semin Immunopathol       Date:  2018-10-23       Impact factor: 9.623

9.  Acute postischemic treatment with estrogen receptor-alpha agonist or estrogen receptor-beta agonist improves myocardial recovery.

Authors:  Nicholas D Vornehm; Meijing Wang; Aaron Abarbanell; Jeremy Herrmann; Brent Weil; Jiangjing Tan; Yue Wang; Megan Kelly; Daniel R Meldrum
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

10.  The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data.

Authors:  Alexander Melamed; Frank J Sorvillo
Journal:  Crit Care       Date:  2009-02-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.